INSR and Parkinson disease: Similarly, loss of insulin receptor immunoreactivity and messenger RNA in the substantia nigra pars compacta of patients with PD correlates with loss of tyrosine hydroxylase messenger RNA (i.e., the rate-limiting enzyme in dopamine synthesis) [346,347].